Prospeo
Hero Section BackgroundHero Section Background
Minoryx Therapeutics

Minoryx Therapeutics

Biotechnology ResearchFlag of ESMataró, Catalonia, Spain21-50 Employees

Company overview

HeadquartersAv. Ernest Lluch 32, TCM2, Mataró, Barcelona 08302, ES
Phone number+34937021975
Website
SIC873
Keywords
Rare Diseases, Neurometabolic Diseases, Friedreich'S Ataxia, X-Linked Adrenoleukodystrophy, Orphan Cns
Founded2011
Employees21-50
Socials

Key Contacts at Minoryx Therapeutics

Flag of ES

Damia Tormo

Director

Flag of ES

Marc Martinell

Co-Founder & Ceo

Flag of ES

Ana Orozco

Director Of Regulatory Affairs

Flag of ES

Josep Roca-I-Camps

Group Finance Director

Flag of ES

Laura Rodríguez Pascau

Director Of Biology

Flag of ES

Marta Torres Galtes

Director Hr & Office

Minoryx Therapeutics Email Formats

Minoryx Therapeutics uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@minoryx.com), used 80% of the time.

FormatExamplePercentage
{first name}{last name}
johndoe@minoryx.com
80%
{last name}{last name}
doedoe@minoryx.com
16%
{first name}.{last name}
john.doe@minoryx.com
4%

About Minoryx Therapeutics

Minoryx is a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company’s lead program, leriglitazone (MIN-102), a novel, brain penetrant and selective PPAR gamma agonist, is being developed in X-linked Adrenoleukodystrophy (X-ALD) and other orphan CNS diseases. The company is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chiesi Ventures, S.R.I.W, Idinvest Partners / Eurazeo, SFPI-FPIM, HealthEquity, Sambrinvest and Herrecha, and has support from a network of other organizations. Minoryx was founded in 2011, is headquartered in Spain with Belgian facilities and has so far raised more than €120 million

$

Minoryx Therapeutics revenue & valuation

Annual revenue$4,420,000
Revenue per employee$130,000
Estimated valuation?$14,200,000
Total funding$86,100,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager
Director
C-Suite

Employees by Department

Minoryx Therapeutics has 17 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Minoryx Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2022-07-016$54,700,000
2025-08-109$31,400,000

Funding Insights

$86,100,000

Total funding amount

$31,400,000

Most recent funding amount

2

Number of funding rounds

Minoryx Therapeutics Tech Stack

Discover the technologies and tools that power Minoryx Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

reCAPTCHA

Security

jQuery

jQuery

JavaScript libraries

Quantcast Measure

Quantcast Measure

Analytics

Google Tag Manager

Google Tag Manager

Tag managers

Quantcast Choice

Quantcast Choice

Cookie compliance

Nginx

Nginx

Reverse proxies

PHP

PHP

Programming languages

Open Graph

Open Graph

Miscellaneous

IONOS

IONOS

Hosting

lit-element

lit-element

JavaScript libraries

jQuery UI

jQuery UI

JavaScript libraries

Google Maps

Google Maps

Maps

Frequently asked questions

Minoryx Therapeutics is located in Mataró, Catalonia, ES.
You can reach Minoryx Therapeutics at +34937021975.
Minoryx Therapeutics was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.
Minoryx Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
Minoryx Therapeutics has raised a total of $86,100,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles